Health Care Resource Use and Costs for Crohn’s Disease before and after Infliximab Therapy
BACKGROUND: Infliximab therapy in patients with Crohn’s disease decreases resource use; however, the overall impact on health-related expenditures is unclear, especially beyond one year of study.
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2011-01-01
|
| Series: | Canadian Journal of Gastroenterology |
| Online Access: | http://dx.doi.org/10.1155/2011/157604 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832559300485054464 |
|---|---|
| author | Dustin E Loomes Christopher Teshima Philip Jacobs Richard Fedorak |
| author_facet | Dustin E Loomes Christopher Teshima Philip Jacobs Richard Fedorak |
| author_sort | Dustin E Loomes |
| collection | DOAJ |
| description | BACKGROUND: Infliximab therapy in patients with Crohn’s disease decreases resource use; however, the overall impact on health-related expenditures is unclear, especially beyond one year of study. |
| format | Article |
| id | doaj-art-a69ddb9bb80045b9b3dc51fcfee4a69f |
| institution | Kabale University |
| issn | 0835-7900 |
| language | English |
| publishDate | 2011-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Canadian Journal of Gastroenterology |
| spelling | doaj-art-a69ddb9bb80045b9b3dc51fcfee4a69f2025-02-03T01:30:29ZengWileyCanadian Journal of Gastroenterology0835-79002011-01-0125949750210.1155/2011/157604Health Care Resource Use and Costs for Crohn’s Disease before and after Infliximab TherapyDustin E Loomes0Christopher Teshima1Philip Jacobs2Richard Fedorak3Division of Gastroenterology, University of Alberta, Edmonton, Alberta, CanadaDivision of Gastroenterology, University of Alberta, Edmonton, Alberta, CanadaDivision of Gastroenterology, University of Alberta, Edmonton, Alberta, CanadaDivision of Gastroenterology, University of Alberta, Edmonton, Alberta, CanadaBACKGROUND: Infliximab therapy in patients with Crohn’s disease decreases resource use; however, the overall impact on health-related expenditures is unclear, especially beyond one year of study.http://dx.doi.org/10.1155/2011/157604 |
| spellingShingle | Dustin E Loomes Christopher Teshima Philip Jacobs Richard Fedorak Health Care Resource Use and Costs for Crohn’s Disease before and after Infliximab Therapy Canadian Journal of Gastroenterology |
| title | Health Care Resource Use and Costs for Crohn’s Disease before and after Infliximab Therapy |
| title_full | Health Care Resource Use and Costs for Crohn’s Disease before and after Infliximab Therapy |
| title_fullStr | Health Care Resource Use and Costs for Crohn’s Disease before and after Infliximab Therapy |
| title_full_unstemmed | Health Care Resource Use and Costs for Crohn’s Disease before and after Infliximab Therapy |
| title_short | Health Care Resource Use and Costs for Crohn’s Disease before and after Infliximab Therapy |
| title_sort | health care resource use and costs for crohn s disease before and after infliximab therapy |
| url | http://dx.doi.org/10.1155/2011/157604 |
| work_keys_str_mv | AT dustineloomes healthcareresourceuseandcostsforcrohnsdiseasebeforeandafterinfliximabtherapy AT christopherteshima healthcareresourceuseandcostsforcrohnsdiseasebeforeandafterinfliximabtherapy AT philipjacobs healthcareresourceuseandcostsforcrohnsdiseasebeforeandafterinfliximabtherapy AT richardfedorak healthcareresourceuseandcostsforcrohnsdiseasebeforeandafterinfliximabtherapy |